Insider Transactions in Q1 2025 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2025
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.74%
|
$1,248
$3.73 P/Share
|
|
Jan 10
2025
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,106
-1.16%
|
$9,318
$3.73 P/Share
|
|
Jan 10
2025
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-0.57%
|
$1,368
$3.73 P/Share
|
|
Jan 09
2025
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
4,049
-5.06%
|
$12,147
$3.8 P/Share
|
|
Jan 09
2025
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+34.92%
|
-
|
|
Jan 09
2025
|
Heidi Henson Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,789
+22.22%
|
-
|
|
Jan 09
2025
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,789
+19.49%
|
-
|
|
Jan 09
2025
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,789
+19.46%
|
-
|
|
Jan 09
2025
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,356
-3.19%
|
$82,068
$3.8 P/Share
|
|
Jan 09
2025
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+21.53%
|
-
|
|
Jan 09
2025
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,422
-2.9%
|
$22,266
$3.8 P/Share
|
|
Jan 09
2025
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+22.19%
|
-
|
|
Jan 09
2025
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,789
+17.49%
|
-
|
|
Jan 09
2025
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,789
+19.55%
|
-
|